bioAffinity Surges to 192nd in Daily Rankings with 4.31 Billion in Trading Volume

On April 1, 2025, bioAffinity(BIAF) experienced a significant surge in trading volume, reaching 4.31 billion, a remarkable 1545.57% increase from the previous day. This surge placed bioAffinity at the 192nd position in the daily stock market rankings, with the stock price rising by 319.23%.

bioAffinity Technologies, a healthcare diagnostics company specializing in cancer detection, is preparing for a pivotal clinical trial. The company is narrowing its focus on its innovative lung cancer test, aiming to enhance early detection and improve patient outcomes. This strategic move underscores bioAffinity's commitment to advancing cancer diagnostics and potentially revolutionizing the way lung cancer is detected and treated.